LEASE by and between BMR-6300 DUMBARTON CIRCLE LP, a Delaware limited partnership and ASTERIAS BIOTHERAPEUTICS, INC., a Delaware corporationLease • March 17th, 2014 • Biotime Inc • Biological products, (no disgnostic substances)
Notwithstanding anything to the contrary in the above chart, during the first fifteen (15) months of the Term (and provided that Tenant is not then in default (beyond any applicable notice and cure periods) of any of its obligations under this Lease), Tenant’s Base Rent shall be calculated based upon twenty-two thousand (22,000) square feet of Rentable Area; provided, however, that Tenant shall have access to and use of the entire Premises subject to and in accordance with the terms and provisions of the Lease.
OPTION AGREEMENTOption Agreement • March 17th, 2014 • Biotime Inc • Biological products, (no disgnostic substances) • California
This Option Agreement (“Option”) is entered into as of March 4, 2014 (the “Effective Date”) by BioTime, Inc., a California corporation (the “Company”), and Milton H. Dresner, Trustee of the Milton H. Dresner Revocable Living Trust (the “Purchaser”) in connection that certain Preferred Stock Purchase Agreement, dated March 4, 2014, between the Company and Purchaser (the “Securities Purchase Agreement”).
SERIES A CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENTSeries a Convertible Preferred Stock Purchase Agreement • March 17th, 2014 • Biotime Inc • Biological products, (no disgnostic substances) • New York
THIS SERIES A CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (this “Agreement”) is entered into as of March 4, 2014 (the “Effective Date”) by and between BioTime, Inc., a California corporation (the “Company”) and each of the undersigned identified on the signature page attached hereto (each such undersigned, individually and/or collectively, as applicable, a “Purchaser").
